chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Anaphylactic reaction to Pfizer COVID 19 Vaccine; This is a spontaneous report received from non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A female patient received BNT162b2 (BNT162B2), on 21Apr2021 as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Mast Cell Disease" (unspecified if ongoing), notes: Mast Cell Disease. The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (first dose), for Covid-19 Immunization. The following information was reported: ANAPHYLACTIC REACTION (medically significant) with onset 21Apr2021, outcome "unknown", described as "Anaphylactic reaction to Pfizer COVID 19 Vaccine". The event "anaphylactic reaction to pfizer covid 19 vaccine" required emergency room visit.  Clinical course: Patient Age at Time of Vaccination in Years was unknown, she believes mid-30s. Event reported as Anaphylactic Reaction to Pfizer BioNTech, clarified to Pfizer COVID 19 Vaccine. She does not believe it was Comirnaty yet. Outcome was reported that the patient believed it resolved, she was unsure if it completely resolved, or it her acquaintance has lasting effects. The acquaintance didn't mention lasting results but didn't specify. Concomitant medications were unknown. The acquaintance did tell her, and she wrote down that the acquaintance has mast cell disease and is randomly allergic to things. That may be a different part of the survey. She clarified that she doesn't know if the acquaintance takes medication for that, she doesn't know what disease entails. History of all previous immunization with the Pfizer vaccine considered as suspect (or patient age at first and subsequent immunizations if dates of birth or immunizations are not available): None, first dose. The acquaintance did say she got the second dose. Unknown NDC/lot/expiry or date of second dose. Patient visited Emergency Room. Her acquaintance went to the hospital and the hospital wanted to admit her and she did not and signed a form. Confirmed the acquaintance was not hospitalized. The hospital made the acquaintance sign a form because she refused to be admitted. Prior Vaccinations (within 4 weeks) If applicable, list any other vaccinations within four weeks prior to the first administration date of the suspect vaccine(s) and AE(s) following prior vaccinations was reported as Unknown.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Hurting all over, general bad feeling, unable to function. Pain eased but general all over ill feeling last several day and kept me in the bed, swelling and pain at site of injection.
Mixed Series. Patient come in for a COVID shot. He said it was his 2nd, but did not have his immunization card with him. When asked, he said he had had Moderna for his 1st dose. We gave him Moderna. When pt brought his vaccine card in a few days later to be completed, it was discovered that he actually received Pfizer for his 1st dose. Timing was appropriate (4/18/21 for Pfizer, 5/31/21 for Moderna).
A pediatrician reported that a 6 month old female received Prevnar on 09/21/2000. The physician reported that the mother stated the infant developed a fever of 99.9 to 100.5 F, fussiness, irritability, and difficulty sleeping on the day of immunization. On 09/23/00, the infant was seen in an emergency room after a 2-3 minute episode of "squeezing eyes shut, thrusting her head backwards, jerking, and rhythmic movements of her head". The reporter indicated that this infant experienced a seizure, however, she was "not post ictal" after the episode. Unspecified lab work and a CT scan were normal. On 09/26/00, the irritability resolved. This event is considered medically important.
This spontaneous report was received from a physician and refers to an 1-year-old patient of unknown gender. The patient's concurrent condition, medical history and concomitant therapies were not reported. On 04-FEB-2019, the patient was vaccinated with a dose of improperly stored MMR II, therapy type rHA (recombinant human albumin), lot# N032750, expiration date 20-NOV-2019, (dose, route of administration were not reported) for prophylaxis. MMR II was improperly stored above 47 degrees Fahrenheit (54.1 F) for 5 hours. Data logger was not involved. No adverse effects were reported. This is one of two reports received from the same reporter. Sender's Comments: US-009507513-1902USA002311.
I am a nurse practitioner working in acute health care.  Have always been asymptomatic and remain asymptomatic to date.  COVID 19 negative 9/8/20 but tested C19+ yesterday in anticipation of having a dermatological procedure tomorrow.  Learned that 3 other employees tested + to C19 after receiving Moderna vaccination. Will remain in quarantine for 10 days and self observe for symptoms.
patient reported whole body severe nerve pain, loss of appetite, trouble walking and moving, trouble talking and writing
pain on the left side that appeared after 5 days Pain in the whole left side of the torso; wich intensified at the level of the neck (parasympathetic ganglion) and spleen area; wich intensified at the level of the neck (parasympathetic ganglion) and spleen area; in the spleen area when breathing, talking, coughing and moving; in the spleen area when breathing, talking, coughing and moving; This is a spontaneous report from a contactable consumer or other non hcp. A patient received bnt162b2 (PFIZER- BIONTECH COVID- 19 VACCINE, Solution for injection, Batch/Lot number was not reported), dose 2 via an unspecified route of administration, in arm left on 07May2021 09:00  as 2nd dose, single dose for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient previously received bnt162b2 (PFIZER- BIONTECH COVID- 19 VACCINE, Solution for injection), dose 1 via an unspecified route of administration, administered in arm left on 07Apr2021 09:00 (Batch/Lot number was not reported) as 1st dose, single dose for covid-19 immunisation and aspirin. On 10May2021, the patient experienced pain on the left side that appeared after 5 days pain in the whole left side of the torso, which intensified at the level of the neck (parasympathetic ganglion) and spleen area and in the spleen area when breathing, talking, coughing and moving. The patient underwent lab tests and procedures which included covid test: negative on 28May2021. The outcome of the events was unknown.  Follow-up attempts are possible. Further information is expected.
COVID-19 treatment; COVID-19 treatment; This is a spontaneous report received from contactable reporter (Consumer or other non HCP). The reporter is the patient.  A 70-year-old female patient (not pregnant) received bnt162b2 omi xbb.1.5 (COMIRNATY (2023-2024 FORMULA)), on 13Oct2023 at 10:15 as dose 1, single (Batch/Lot number: unknown) at the age of 70 years, in left arm for COVID-19 immunisation. The patient's relevant medical history included: "Mild hypertension" (unspecified if ongoing); "Depression" (unspecified if ongoing). Concomitant medications included: HYDROCHLOROTHIAZIDE, start date: 03Feb2022; SERTRALINE. Vaccination history included: Moderna COVID-19 vaccine (dose 6 (booster), single; lot number: 067H22A; site: left arm), administration date: 08Dec2022, when the patient was 69-year-old, for COVID-19 immunization; Moderna COVID-19 vaccine (dose 5 (booster), single; lot number: AS7147B; site: left arm), administration date: 19Sep2022, when the patient was 69-year-old, for COVID-19 immunization; Moderna COVID-19 vaccine (dose 4 (booster), single; lot number: unknown; site: left arm), administration date: 05Apr2022, when the patient was 68-year-old, for COVID-19 immunization; Moderna COVID-19 vaccine (dose 3 (booster), single; lot number: 939904; site: left arm), administration date: 28Oct2021, when the patient was 68-year-old, for COVID-19 immunization; Moderna COVID-19 vaccine (dose 2, single; lot number: 025AZ1A; site: left arm), administration date: 25Feb2021, when the patient was 67-year-old, for COVID-19 immunization; Moderna COVID-19 vaccine (dose 1, single; lot number: 007M20A; site: left arm), administration date: 26Jan2021, when the patient was 67-year-old, for COVID-19 immunization. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "COVID-19 treatment". Therapeutic measures were taken as a result of drug ineffective, COVID-19 which included Paxlovid 300-100 MG pack from 21Oct2023 to 26Oct2023.  The information on the batch/lot number for bnt162b2 omi xbb.1.5 has been requested and will be submitted if and when received.
Patient developed acute Herpes Zoster following administration of ZOSTAVAX. Patient treated with VALTREX and pain medication.
This infant had fussiness within 24 hours after his shot lasting for more than 6 days, decreased sucking, and difficulty falling asleep.
Pt fainted for a second and hit his head.  He immediately got up and was given water and an ice pack.  He was asked to sit for a bit until he felt much better.  He felt better right away but we had him sit for about 1/2 hour.  He had not had anything to eat all day
Patient reported nausea.   The pharmacy provided him a waste basket to hold his vomit as well as an ice pack and water.  Patient says that he "felt..[his] blood sugar go down".   He said he hadn't eaten all day.    I called him 4 days later and he said that he felt better later that day, but just tired.  Before 2nd vaccination dose,  patient said he only had arm soreness & pain after 1st dose.
PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE; OFF LABEL USE; This spontaneous report received from a physician concerned a 12 year old male. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine (suspension for injection, route of admin not reported, batch number: Unk) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On an unspecified date, the subject experienced product administered to subject of inappropriate age, and off label use. The action taken with covid-19 vaccine  was not applicable. The outcome of the product administered to patient of inappropriate age and off label use was not reported. This report was non-serious.
sneezing and a runny nose off and on; sneezing and a runny nose off and on; Initial information received on 06-Nov-2019 regarding an unsolicited valid non-serious case received from a nurse.  This case involves a 33 years old male patient who experienced sneezing and a runny nose off and on [Sneezing and Rhinorrhoea], while he received vaccine INFLUENZA QUADRIVAL A-B VACCINE [FLUZONE QUADRIVALENT].  The patient's past Medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date in fall of 2018, the patient received a dose of suspect INFLUENZA QUADRIVAL A-B VACCINE [lot number and Exp. Date not reported] via unknown route in unknown administration site for prophylactic vaccination.  On an unknown date, (latency unknown) the patient experienced sneezing and a runny nose off and on [Sneezing and Rhinorrhoea], following administration of vaccine.  (Other relevant tests included no lab data)  Final diagnosis was runny nose and sneezing.   It was not reported if the patient received a corrective treatment.  The patient outcome is reported as Unknown for runny nose and as Unknown for sneezing.  Information on the batch number was requested.
No additional AE; patient received MMR II expired 4/23/2023.; This spontaneous report was received from an other health professional and refers to a patient of unknown age and gender.  The patient's medical history, concurrent conditions and concomitant therapies were not reported.  On 23-MAY-2023, the patient was vaccinated with expired dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live recombinant human albumin (rHa) (M-M-R II) injection, lot #U013036, expiration date 23-APR-2023 and administered for prophylaxis (strength, lot #, expiry date, and route of administration were not provided) (Expired product administered). No additional adverse events were reported.
Redness, swelling, and pain after a few hours.  Lasting for 5 days.  MOTRIN, TYLENOL and BENADRYL given.
Throat immediately began to close  after 30-60 seconds after receiving the vaccination.  Tongue was swelling and difficulty swallowing. The pharmacy gave me two Benadryl and water.  My friend drove me to the hospital where I received steroids, Pepcid, and other drugs to stop the anaphylactic reaction.
Vaccine stored in refrigerator 21-Sep-2021, expired product 09-Oct-2021, administered date on 13-Oct-2021; 606 doses were given after expiration date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (606 doses were given after expiration date) and PRODUCT STORAGE ERROR (Vaccine stored in refrigerator 21-Sep-2021, expired product 09-Oct-2021, administered date on 13-Oct-2021) in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Oct-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (606 doses were given after expiration date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine stored in refrigerator 21-Sep-2021, expired product 09-Oct-2021, administered date on 13-Oct-2021). At the time of the report, EXPIRED PRODUCT ADMINISTERED (606 doses were given after expiration date) and PRODUCT STORAGE ERROR (Vaccine stored in refrigerator 21-Sep-2021, expired product 09-Oct-2021, administered date on 13-Oct-2021) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication were reported. No treatment information were provided. Patient did not reported any adverse events. The vials did not undergo any temperature excursion. The vaccine was kept in the refrigerator on 21-Sep-2021.
Small patch of red, raised, rashy, sensitive skin on right thigh (outer) at point of vaccination administration. Very fussy for several days.
Discharge Provider: DO  Primary Care Physician at Discharge: MD  Admission Date: 8/10/2022  Discharge Date: 8/15/2022   Diarrhea, unspecified type [R19.7] Diarrhea due to COVID-19 [U07.1, A08.39] COVID-19 virus detected [U07.1]   HOSPITAL COURSE: Patient is a 13yo with PMHx DiGeorge, chronic lung disease, adrenal insufficiency, congenital heart disease, focal epilepsy, anxiety, hypothyroidism, GERD who presented to the ED on 8/10 with diarrhea and fever. He was subsequently diagnosed with COVID and admitted for further management.   Since admission, patient was received remdesivir since he was at high risk of complications secondary to COVID. Labs were ordered to ensure that he was handling the remdesivir okay. He was also switched to decadron in place of the hydrocortisone for his stress dosing for his adrenal insufficiency.    Patient was also at risk for thrombosis due to limited mobility, history of thrombus and because he was Covid positive. Heme/Onc was consulted and recommended Lovenox every 12h while admitted.    While admitted, his peripheral blood cultures grew staph hominis which was likely due to contamination from skin flora. On repeat blood cultures, there was no growth at the time of discharge. Infectious disease was consulted and will be following the results of the blood cultures after discharge to ensure that no antibiotics are needed.    Patient continued all home medications while admitted. He was also at his Yellow zone while hospitalized and received CPT BID, flovent, albuterol and his other home medications.   On day of discharge, patient remained medically stable. Diarrhea has improved to less frequent bowel movements which are somewhat firmer than before. Peripheral blood cultures will be followed by Infectious Disease after discharge and patient will be notified if they grow anything. Patient will resume all home medications and will not need a taper for his stress dosing of steroids.
My lips became numb around 2-3 hours after my shot on February 3rd.  I took 2 Benadryl before I went to bed.  The following morning  2/4 I experienced for a short time warmth and tingling down both of my arms but it then went away and my lips were still numb.  I again took 2 Benadryl that morning and again 2 Benadryl that night.  The following morning 2/5 my lips were still numb and again I took 2 Benadryl in the AM and also in the PM.  The next morning 2/6 I woke up have chills and shaking and my lips still numb.  At that time I called 911 and was taken to  Hospital and treated for an allergic reaction with at IV of Dexamethasone and Pepcid through an IV.  They watched me for around 2 hours and I was then discharged to go home with a script for Dexamethasone pills to take again on Monday morning.  As I write this my lips are still numb, but I have no other symptoms.
immediately after injection, facial flushing, then continuous waves of flushing and chills through body, from abdomen to toes, lightheadedness, cold hands and feet. This occurred for several hours and did not worsen nor did this improve. Tongue felt numb, and mouth was dry.  Tongue felt swollen, however, the tongue size was normal. No rash, no fever and no shaking. Blood pressure, Oxygen saturation were normal. No breathing difficulties. I was observed in the ER and administered iv Benadryl 25 mg and pepcid, and iv fluids. I woke up a few hours later. I still had the rushes of chills, numb tongue, and cold hands and feet. I was discharged to home. I still have the rushes of flushing and chills that flows through my body.
Patient came in for an MA visit for her second HPV9 shot. Waiting the initial period for immediate reaction before releasing the patient. The mother called the next day to report a possible reaction to vaccine. This is the phone mssg: "Pt got HPV booster 1/20/20. Pt has symptoms now and mom not sure if symptoms are related or not. She has been vomiting and very sharp painful HA since yesterday night. Unsure fever, pain under right rib. Tylenol did not help with pain. No visible reaction at injection site.  Per mom she did not have reaction with first shot."
The patient removed bandaid at nigh on 8/22/19.  On 8/24/19 patient started to experience pain and inflammation to the point she cannot lift her arm above her head.  The pharmacist recommended to apply a cold pack to the area and start taking Ibuprofen 200mg two tablets every 6 hours.  And she will call back in two days.
experienced injection site pain; This case was reported by a physician and described the occurrence of injection site pain in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced injection site pain. On an unknown date, the outcome of the injection site pain was unknown.   It was unknown if the reporter considered the injection site pain to be related to Shingrix.  Additional details were provided as follows: Age group was consider as adult as per vaccine indication. Doctor stated that a patient experienced injection site pain. The reporter consented to follow up.
Patient was screened for contraindications, and had no true contraindications. Patient and Mother was advised to stay for 15 minutes for observation after receiving vaccines. Parent Verbalized understanding.    Meningococcal (MCV-4) IM and Tdap (adol/adult formulation) IM, and HPV (Human Papilloma Virus) IM given per protocol using proper technique. At 1124 after receiving the HPV vaccine, patient began to clench her fists bringing her arms closer to her body that lasted 4-5 seconds as she looked up and responded, "what happened?, am I done getting vaccines?". Instructed patient to take deep breaths. No lip biting and grinding of the teeth was noted. I immediately obtained vital signs while she remained seated while also asking her for her name and date of birth, location and who did she come with. Patient was oriented to place and person. First vital signs were obtained at 1125a BP 69/48 HR 55 O2 saturation at 95% skin complexion was pale with no sweating noted while patient was asked if anything was wrong, and stated, "i feel dizzy and nauseated". Mother stated patient had no prior history of vaccine reaction and reported no allergies at this time, and patient had nothing to eat this morning.  Patient remained conscious, Second set of Vitals signs were obtained at 1130a BP 82/52, HR 62 O2 saturation at 96%. Third set of vitals obtained at 1135 BP 99/65 HR 68 O2 saturation at 98%. Skin color returned with no signs of discoloration noted. Patient remained conscious and talkative. Vital signs obtained at 11:43a BP 103/70, HR 74 O2 saturation at 98%.. Patient was stable and was able to stand without assistance while I remained next to her, and was able to walk with no assistance. Parent and patient were educated to call for emergency care if symptoms return or worsen. Parent and patient verbalized understanding and released from my care our care at 11:48a  Provider was notified and VAERS report submitted
Shortly after receiving the Covid 19 booster shot I was on work assignment. Within a few days I tested positive for Covid 19 as well as several other people. We recovered but I noticed I still had a chronic cough. With this going on our ship started to head into the tropics. I love the tropical weather. As I am coughing I noticed I didn?t want to be outside. It was overbearing. Then my resting heart rate felt like it was 1000 miles per hour. I saw the ship?s medical and asked about it. I was informed my heart rate was 125BPM at rest. They thought my body was just under stress due to being at sea. I?ve been employed for 12 years and I need it wasn?t from that. 2 months pass by with the heart rate going at 125+BPM and I started to lose weight. I was 210 pounds starting work assignment and at this time I was down to 175 pounds. I was not dieting. In fact I was making it a point to eat more food because I noticed I was dropping weight. I was flown off the ship to inland where they did blood work and discovered I had a hyperthyroidism.
When giving the injection some of the vaccine leaked out between the syringe and the needle hub. Needle was on tight.  Contacted Pfizer and they recommended re-vaccinating patient and filled safety report . Contacted clinic manager as well.  Patient has not yet been revaccinated due to unable to contact patient via phone. Compelted at clinic.
RN reported that she suddenly feared she may have given 1mL instead of 0.5mL after the shot.RN is not sure why she suddenly felt that way except for a sudden doubt that came to her mind. It is quite likely that patient did just receive the correct 0.5mL dose and that the RN's worry was unfounded.Patient was called the following morning to check in on his symptoms if any by RN.Patient noted to have a fever,congestion and nauseau during the night.